Developmental changes of fluconazole clearance in neonates and infants in relation to ontogeny of glomerular filtration rate: literature review and data analysis

[1]  N. Holford,et al.  Understanding dosing: children are small adults, neonates are immature children , 2013, Archives of Disease in Childhood.

[2]  M. Laughon,et al.  Fluconazole pharmacokinetics and safety in premature infants. , 2012, Current medicinal chemistry.

[3]  P. Smith,et al.  Fluconazole Loading Dose Pharmacokinetics and Safety in Infants , 2011, The Pediatric infectious disease journal.

[4]  Young-mee Ahn.  Formula and scale for body surface area estimation in high-risk infants. , 2010, Collegium antropologicum.

[5]  S. Anderson,et al.  The aging kidney: physiological changes. , 2010, Advances in chronic kidney disease.

[6]  M. Nahata,et al.  Pharmacokinetics of fluconazole in young infants , 1999, European Journal of Drug Metabolism and Pharmacokinetics.

[7]  M. Coulthard,et al.  Human renal function maturation: a quantitative description using weight and postmenstrual age , 2009, Pediatric Nephrology.

[8]  Amin Rostami-Hodjegan,et al.  Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children , 2006, Clinical pharmacokinetics.

[9]  S. Vučinić,et al.  A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. , 2005, Clinical therapeutics.

[10]  A. J. Heijden,et al.  Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age , 1988, European Journal of Pediatrics.

[11]  M. Nahata,et al.  Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection , 2004, European Journal of Clinical Pharmacology.

[12]  Susan M Abdel-Rahman,et al.  Developmental pharmacology--drug disposition, action, and therapy in infants and children. , 2003, The New England journal of medicine.

[13]  S. Ishikawa,et al.  Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children , 2000, Clinical pharmacology and therapeutics.

[14]  H. Hörnchen,et al.  Pharmacokinetics of oral fluconazole in premature infants , 1998, European Journal of Pediatrics.

[15]  G. Haycock.  Development of glomerular filtration and tubular sodium reabsorption in the human fetus and newborn. , 1998, British journal of urology.

[16]  W. Hickerson,et al.  Fluconazole Pharmacokinetics in Burn Patients , 1998, Antimicrobial Agents and Chemotherapy.

[17]  W. Evans,et al.  Liver volume as a determinant of drug clearance in children and adolescents. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[18]  S. Tett,et al.  Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection , 1995, Antimicrobial agents and chemotherapy.

[19]  B. Bostrom,et al.  Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease , 1995, Pharmacotherapy.

[20]  A. Hartmann,et al.  The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients. , 1994, British journal of clinical pharmacology.

[21]  T. Okabe,et al.  BE-23372M, a novel protein tyrosine kinase inhibitor. I. Producing organism, fermentation, isolation and biological activities. , 1994, The Journal of antibiotics.

[22]  H. Wada,et al.  [Clinical study of fluconazole-injectable and -granules in pediatric patients]. , 1994, The Japanese journal of antibiotics.

[23]  K. Sunakawa,et al.  [Pharmacokinetic and clinical studies on fluconazole in the pediatric field]. , 1994, The Japanese journal of antibiotics.

[24]  H. Nakano,et al.  UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces. , 1993, The Journal of antibiotics.

[25]  J. Scavone,et al.  Pharmacokinetics and bioavailability of fluconazole in patients with AIDS , 1993, Antimicrobial Agents and Chemotherapy.

[26]  K. Hoppu,et al.  Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life , 1993, Clinical pharmacology and therapeutics.

[27]  Y. Sakiyama,et al.  [A clinical study of fluconazole-granules and -injectable in pediatric patients with deep-seated mycoses]. , 1993, The Japanese journal of antibiotics.

[28]  M. Prenna,et al.  Pharmacokinetics of fluconazole in normal volunteers. , 1993, Chemotherapy.

[29]  R. Yeates,et al.  Single dose intravenous pharmacokinetics of fluconazole in infants. , 1993, Drugs under experimental and clinical research.

[30]  T. Walsh,et al.  Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. , 1992, The Journal of pediatrics.

[31]  S. Fowler,et al.  Fluconazole in neonatal disseminated candidiasis. , 1991, Archives of disease in childhood.

[32]  J. Thorpe,et al.  Effect of Oral Antacid Administration on the Pharmacokinetics of Oral Fluconazole , 1990, Antimicrobial Agents and Chemotherapy.

[33]  I. Fong,et al.  Pharmacokinetics of Fluconazole in Serum and Cerebrospinal Fluid in a Patient with AIDS and Cryptococcal Meningitis , 1990, Pharmacotherapy.

[34]  T. Miyahara,et al.  Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects. , 1990, Clinical therapeutics.

[35]  P. Macrae,et al.  Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis , 1990, Antimicrobial Agents and Chemotherapy.

[36]  J. K. Faulkner,et al.  Pharmacokinetics and tissue penetration of fluconazole in humans. , 1990, Reviews of infectious diseases.

[37]  R. Gokal,et al.  An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole. , 1990, British journal of clinical pharmacology.

[38]  M J Humphrey,et al.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.

[39]  M. Coulthard,et al.  Maturation of glomerular filtration in preterm and mature babies. , 1985, Early human development.

[40]  C. Fawer,et al.  Maturation of renal function in full-term and premature neonates. , 1979, Helvetica paediatrica acta.

[41]  G. Schwartz,et al.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.

[42]  A. Augsberger.  Old and new rules for dosage determination in paediatrics. , 1962, Triangle; the Sandoz journal of medical science.

[43]  J. Crawford,et al.  Simplification of drug dosage calculation by application of the surface area principle. , 1950, Pediatrics.

[44]  M. Rubin,et al.  Maturation of renal function in childhood; clearance studies. , 1949, The Journal of clinical investigation.

[45]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[46]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .